SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited has issued an update revealing the exercise of 207,900 Share Options under its Post-IPO Option Plan, resulting in the issuance of an equivalent number of new shares. This exercise brings the total number of shares in the company to 630,543,012, with a remaining 66,231,052 Share Options still outstanding. This announcement is part of the process for the proposed company privatisation by Silver Pegasus Investment Limited.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.